Investing Profile

Vasudev Bailey

General Partner at ARTIS Ventures

av.co/vasudev-baileySan Francisco, California

Your Intro Paths to Vasudev Bailey

Signal uses Gmail to reveal intro paths. Email content is never read.

Networks Vasudev is a member of

Mckinsey & Company Network

669 CONNECTIONS

University of California, Irvine Network

56 CONNECTIONS

University of California, Irvine Network

56 CONNECTIONS

UC Irvine Network

50 CONNECTIONS

GLG Network

35 CONNECTIONS

Find Vasudev Bailey on

Current Investing Position

Artis Ventures (AV) General Partner

Investment Range

$250K - $25.0M

Sweet Spot

$10.0M

Investments On Record

Vasudev Bailey is on these Sector & Stage Rankings

BioTech (Seed)BioTech (Series A)Health IT (Series A)San Francisco Bay Area Health IT (Seed)

Vasudev Bailey's Investments On Record (11)

Company	StageDateRound Size	Total Raised
Unnatural Products	Series BMar 2026$45M Series ADec 2023$32M SeedSep 2019$6M	$83M
Co-investors: Ameena El-Bibany (Artis Ventures (AV)), Prem Tumkosit (Cardiaccs AS), Nicholas Shekerdemian (The Venture Collective (TVC))
Eko Health	Series DJun 2024$41M Series CNov 2020$65M Series BSep 2019$20M Series AMar 2018$5M	$140M
Co-investors: Pieter Kemps (Peak XV Partners (formerly Sequoia Capital India & SEA)), Rob Toews (Radical Ventures), Corey Mulloy (Highland Capital Partners), Ryan Drant (Questa Capital), Stephen Hays (What If Ventures), Jeremy Fiance (The House Fund), Charles Seely (Stealth), Michael Baum
OverT Bio	SeedMay 2024$16M	$16M
Co-investors: Sara Choi (Wing Venture Capital)
Freenome	Series FFeb 2024$250M Series DDec 2021$300M Series BJul 2019$160M	$1.3B
Co-investors: Vijay Pande (Andreessen Horowitz), Amir Nashat (Polaris Venture Partners), Peter Kolchinsky (RA Capital), Jeffrey Schwartz (Cohasset Capital), Skip Fleshman (Asset Management Ventures), Daniel Coley (Cofounders Capital), Anne Wojcicki (23andMe)
Ozlo Sleep	Series AAug 2023$10M	$10M
ONI	Series BDec 2021$75M	$75M
Co-investors: David Schwab (Sierra Ventures), Mike Pellini (Section 32), Paul Conley (Paladin Capital Group), Keith Crandell (ARCH Venture Partners)
Delix Therapeutics	Series ASep 2021$70M	$70M
Co-investors: Andrew Levin (RA Capital Management), Ken Belotsky (Negev Capital), Matias Serebrinsky (PsyMed Ventures)
Excision BioTherapeutics	Series AFeb 2021$60M SeedSep 2017$10M	$81M
Co-investors: Lawrence Jen (Alumni Ventures ), Stuart Peterson (Artis Ventures (AV)), Ben Kong (The Venture Collective (TVC)), Chris Sklarin (Castor Ventures), Anton Simunovic (Castor Ventures (an Alumni Ventures Fund)), Brian Keil (Chestnut Street Ventures), Andre De Baubigny (Modern Venture Partners), Daniel Rothman (Waterman Ventures)

Vasudev Bailey's Experience

DNA Methylation-based Liquid Biopsy Johns Hopkins School of MedicinePresent

DNA Methylation-based Liquid Biopsy Johns Hopkins HospitalPresent

Management Consultant Mckinsey & CompanyPresent

Member Board Of Directors Association for Women in SciencePresent

Board Member Excision BioTherapeutics Part-timePresent

Chairman Of The Board ekoPresent

Board Member Aether Biomachines, Inc Full-timePresent

Board Of Advisors, Department of Biomedical Engineering Johns Hopkins MedicinePresent

Board Member Unnatural Products Part-timePresent

Board Member The Trevor ProjectPresent

General Manager & Co-founder GLG InstitutePresent

General Manager & Co-founder GLGPresent

General Partner ARTIS VenturesPresent

Managing Partner ArtisPresent

Co-Founder HologenPresent

Vasudev Bailey's Education

University of California, Irvine B.S B.S, Biomedical Engineering; Minor: Political Science

The Johns Hopkins University School of Medicine Doctor of Philosophy (PhD) Doctor of Philosophy (PhD), Biomedical Engineering

University of California, Irvine B.S Biomedical Engineering; Minor: Political Science

UC Irvine B.S Biomedical Engineering; Minor: Political Science

The Johns Hopkins University School of Medicine Doctor of Philosophy (PhD) Biomedical Engineering

Investors who invest with Vasudev Bailey

Scouts & Angels Affiliated With Vasudev Bailey